Repression of Glucagon Gene Transcription by Peroxisome Proliferator-activated Receptor γ through Inhibition of Pax6 Transcriptional Activity*
Repression of Glucagon Gene Transcription by Peroxisome Proliferator-activated Receptor γ through Inhibition of Pax6 Transcriptional Activity*
复制标题
过氧化物酶体增殖物激活受体 γ 通过抑制 Pax6 转录活性来抑制胰高血糖素基因转录*
DOI:
10.1074/jbc.m109718200
复制
发表时间:
2002
期刊:
影响因子:
--
通讯作者:
W. Knepel
中科院分区:
文献类型:
--
作者:
S. Schinner;C. Dellas;M. Schröder;C. Heinlein;Chawnshang Chang;J. Fischer;W. Knepel
The nuclear receptor peroxisome proliferator-activated receptor γ (PPARγ) is involved in glucose homeostasis and synthetic PPARγ ligands, the thiazolidinediones, a new class of antidiabetic agents that reduce insulin resistance and, as a secondary effect, reduce hepatic glucose output. PPARγ is highly expressed in normal human pancreatic islet α-cells that produce glucagon. This peptide hormone is a functional antagonist of insulin stimulating hepatic glucose output. Therefore, the effect of PPARγ and thiazolidinediones on glucagon gene transcription was investigated. After transient transfection of a glucagon-reporter fusion gene into a glucagon-producing pancreatic islet cell line, thiazolidinediones inhibited glucagon gene transcription when PPARγ was coexpressed. They also reduced glucagon secretion and glucagon tissue levels in primary pancreatic islets. A 5′/3′-deletion and internal mutation analysis indicated that a pancreatic islet cell-specific enhancer sequence (PISCES) motif within the proximal glucagon promoter element G1 was required for PPARγ responsiveness. This sequence motif binds the paired domain transcription factor Pax6. When the PISCES motif within G1 was mutated into a GAL4 binding site, the expression of GAL4-Pax6 restored glucagon promoter activity and PPARγ responsiveness. GAL4-Pax6 transcriptional activity was inhibited by PPARγ in response to thiazolidinedione treatment also at a minimal viral promoter. These results suggest that PPARγ in a ligand-dependent but DNA binding-independent manner inhibits Pax6 transcriptional activity, resulting in inhibition of glucagon gene transcription. These data thereby define Pax6 as a novel functional target of PPARγ and suggest that inhibition of glucagon gene expression may be among the multiple mechanisms through which thiazolidinediones improve glycemic control in diabetic subjects.
登录
查看更多内容
影响因子:
10.5
作者:
Sander, M;Neubuser, A;German, MS
通讯作者:
German, MS
影响因子:
4.3
作者:
Jacob,ST;Zhang,J;Garg,LC;Book,CB
通讯作者:
Book,CB
影响因子:
2.7
作者:
S. Nordeen
通讯作者:
S. Nordeen
DOI:
10.1210/mend-5-10-1457
发表时间:
1991
期刊:
Molecular endocrinology (Baltimore, Md.)
影响因子:
--
作者:
Knepel,W;Vallejo,M;Chafitz,JA;Habener,JF
通讯作者:
Habener,JF
影响因子:
15.9
作者:
Han, KH;Chang, MK;Quehenberger, O
通讯作者:
Quehenberger, O